Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4911-4914

  Lysnyansky, I ^a   Mikula, I ^a   Gerchman, I ^a   Levisohn, S ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-INFECTIVE AGENTS; DNA TOPOISOMERASE IV; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA BOVIS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 70350310335     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00703-09     Document Type: Article

References (26)

1. Alonso, R., M. Galimand, and P. Courvalin. 2004. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone- resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 53:682-683.
2. Bebear, C., J. Renaudin, A. Charron, H. Renaudin, B. de Barbeyrac, T. Schaeverbeke, and C. Bebear. 1999. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob. Agents Chemother. 43:954-956. (Pubitemid 29165766)
3. Bébéar, C. M., H. Renaudin, A. Charron, M. Clerc, S. Pereyre, and C. Bébéar. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob. Agents Chemother. 47:3323-3325.
4. Bui, M.-H., G. G. Stone, A. M. Nilius, L. Almer, and R. K. Flamm. 2003. PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:1456-1459. (Pubitemid 36368620)
5. Chen, F. J., and H. J. Lo. 2003. Molecular mechanisms of fluoroquinolone resistance. J. Microbiol. Immunol. Infect. 36:1-9.
6. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, S. Maeda, I. Saito, and Y. Kawada. 1996. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J. Clin. Microbiol. 34:2255-2258.
7. Duffy, L., J. Glass, G. Hall, R. Avery, R. Rackley, S. Peterson, and K. Waites. 2006. Fluoroquinolone resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol. 44:1590-1591.
8. Gerchman, I., S. Levisohn, I. Mikula, and I. Lysnyansky. 2009. In vitro antimicrobial susceptibility Mycoplasma bovis isolated in Israel from local and imported cattle. Vet. Microbiol. 137:268-275.
9. Gerchman, I., I. Lysnyansky, S. Perk, and S. Levisohn. 2008. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys. Vet. Microbiol. 131:266-276.
10. Hannan, P. C. 2000. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. Vet. Res. 31:373-395.
11. Hooper, D. C. 1998. Bacterial topoisomerases, anti-topoisomerases, and antitopoisomerase resistance. Clin. Infect. Dis. 27:S54-63.
12. Hopkins, K. L., R. H. Davies, and E. J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents. 25:358-373.
13. Ip, M., S. S. L. Chau, F. Chi, A. Qi, and R. W. M. Lai. 2006. Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism. J. Clin. Microbiol. 44:970-975.
14. Le Carrou, J., M. Laurentie, M. Kobisch, and A. V. Gautier-Bouchardon. 2006. Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene. Antimicrob. Agents Chemother. 50:1959-1966. (Pubitemid 43807512)
15. Lysnyansky, I., M. J. Calcutt, I. Ben-Barak, Y. Ron, S. Levisohn, B. A. Methe, and D. Yogev. 2009. Molecular characterization of newly-identified IS3, IS4 and IS30 insertion sequence-like elements in Mycoplasma bovis and their possible roles in genome plasticity. FEMS Microbiol. Lett. 294:172-182.
16. Lysnyansky, I., I. Gerchman, S. Perk, and S. Levisohn. 2008. Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum. Avian Dis. 52:685-689.
17. Matsuoka, M., M. Narita, N. Okazaki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki, A. Horino, M. Shintani, Y. Arakawa, and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48:4624-4630.
18. Miles, K., L. McAuliffe, A. Persson, R. D. Ayling, and R. A. Nicholas. 2005. Insertion sequence profiling of UK Mycoplasma bovis field isolates. Vet. Microbiol. 107:301-306.
19. NCCLS. 2002. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents; approved guideline M37-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. Ozeki, S., T. Deguchi, M. Nakano, T. Kawamura, Y. Nishino, and Y. Kawada. 1997. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. J. Clin. Microbiol. 35:2315-2319.
21. Page, S., F. Vernel-Pauillac, O. O'Connor, S. Bremont, F. Charavay, P. Courvalin, C. Goarant, and S. Le Hello. 2008. Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 52:4155-4158.
22. Reinhardt, A. K., C. M. Bébéar, M. Kobisch, I. Kempf, and A. V. Gautier-Bouchardon. 2002. Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrob. Agents Chemother. 46:590-593.
23. Thomas, A., A. Linden, J. Mainil, D. F. Bischof, J. Frey, and E. M. Vilei. 2005. Mycoplasma bovis shares insertion sequences with Mycoplasma agalactiae and Mycoplasma mycoides subsp. mycoides SC: evolutionary and developmental aspects. FEMS Microbiol. Lett. 245:249-255.
24. Vernel-Pauillac, F., V. Falcot, D. Whiley, and F. Merien. 2006. Rapid detection of a chromosomally mediated penicillin resistance-associated ponA mutation in Neisseria gonorrhoeae using a real-time PCR assay. FEMS Microbiol. Lett. 255:66-74.
25. Vicca, J., D. Maes, T. Stakenborg, P. Butaye, F. Minion, J. Peeters, A. de Kruif, A. Decostere, and F. Haesebrouck. 2007. Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates. Microb. Drug Resist. 13:166-170.
26. Wolff, B. J., W. L. Thacker, S. B. Schwartz, and J. M. Winchell. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549.